Read + Share
. Casulo C, Dixon JG, Le-Rademacher J, et al; FLASH (Follicular Lymphoma Analysis
of Surrogacy Hypothesis) Group. Validation of POD24 as a robust early clinical
end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood.
2022;139(1 Blood 2026;148:1067.
PMID: 42623096
|
 |
|
